Xiao, Feiyi, Wudong Xiao, Xue Li, Rui Li, and Kun Zhao. 2024. “Cost-Effectiveness Analysis of Trastuzumab Deruxtecan As Second-Line Treatment for HER2- Positive Advanced Breast Cancer”. Health Decision 2 (S1). https://doi.org/10.54844/hd.2024.0009.